HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Design and characterization of highly in vitro antitumor active ternary copper(II) complexes containing 2'-hydroxychalcone ligands.

Abstract
A series of innovative copper(II) complexes of the general composition [Cu(Ln)(phen)]NO3 (1-8; phen=1,10-phenanthroline), involving 2'-hydroxychalcone {(E)-1-(2'-hydroxyphenyl)-3-phenylprop-2-en-1-one} derivatives (HLn) was synthesized, thoroughly characterized and screened for in vitro cytotoxicity against a panel of ten human cancer cell lines. The most promising results were achieved for complex 2 with the best IC50 value of 1.1±0.7μM (against A2780 cell line). The toxicity testing on a primary culture of human hepatocytes (HH) revealed that complex 2 is the least toxic from the whole series with the IC50 value of 63.7μM. The complexes were shown to be able to efficaciously cleave pUC19 plasmid DNA as well as intercalate into calf thymus DNA with the same affinity and efficacy as ethidium bromide and interact by the ligand exchange mechanism with l-cysteine at physiological concentration levels.
AuthorsRadka Křikavová, Ján Vančo, Zdeněk Trávníček, Jakub Hutyra, Zdeněk Dvořák
JournalJournal of inorganic biochemistry (J Inorg Biochem) Vol. 163 Pg. 8-17 (10 2016) ISSN: 1873-3344 [Electronic] United States
PMID27423037 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2016 Elsevier Inc. All rights reserved.
Chemical References
  • Antineoplastic Agents
  • Chalcones
  • Cytotoxins
  • Copper
  • 2'-hydroxychalcone
Topics
  • Antineoplastic Agents (chemical synthesis, chemistry, pharmacology)
  • Chalcones (chemistry, pharmacology)
  • Copper (chemistry, pharmacology)
  • Cytotoxins (chemical synthesis, chemistry, pharmacology)
  • HeLa Cells
  • Hepatocytes (metabolism, pathology)
  • Humans
  • MCF-7 Cells
  • Neoplasms (drug therapy, metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: